Voennaya Elmaz Osmanova (V.I. Vernadsky Crimean Federal University)
Kudashova Sofya Sergeevna (V.I. Vernadsky Crimean Federal University)
Zopunian Leila Arturovna (V.I. Vernadsky Crimean Federal University)
Kapuzian Dzhuliia Gevorgovna (V.I. Vernadsky Crimean Federal University)
Stepannikova Anastasia Romanovna (V.I. Vernadsky Crimean Federal University)
Mamedova Kamilla Muradovna (V.I. Vernadsky Crimean Federal University)
|
The effect of cytostatic therapy with thalidomide and M-2 protocol analogs in the treatment of multiple myeloma (MM) was studied. For this purpose, 34 patients with MM were examined on the basis of the hematology and chemotherapy department of the Crimean Republican Oncological Clinical Center named after VM Efetov, Simferopol. It was established that treatment using thalidomide analogs increases the survival of patients up to 5 years, and when using the M-2 protocol by 4 years. Also, achievement of remission in 11 patients was recorded.
Keywords:Multiple myeloma, thalidomide, M-2 protocol, secreting multiple myeloma, pomalidomide, lenalidomide, neurological intoxication, neuralgia, plasmacytoma, ringworm
|
|
|
Read the full article …
|
Citation link: Voennaya E. O., Kudashova S. S., Zopunian L. A., Kapuzian D. G., Stepannikova A. R., Mamedova K. M. COMPARATIVE CHARACTERISTICS OF THE COMPLICATIONS OF MULTIPLE MYELOMA DURING THERAPY WITH ANALOGUES OF THALIDOMIDE AND M-2 PROTOCOL // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2024. -№11/2. -С. 155-157 DOI 10.37882/2223-2966.2024.11-2.09 |
|
|